COMMUNIQUÉS West-GlobeNewswire

RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai's Platform to Develop a New AI Control System for Clinical AI Performance and Safety
01/12/2024
DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance monitoring, and safety, [...]
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
30/11/2024
All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company [...]
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29/11/2024
BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease [...]
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
29/11/2024
BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today [...]
CorVel Announces Retirement of V. Gordon Clemons
29/11/2024
FORT WORTH, Texas, Nov. 29, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announces V. Gordon Clemons is electing to retire as a member of the Company’s Board of Directors (the “Board”) and as Chairman of [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/11/2024
SAN FRANCISCO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
29/11/2024
PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received [...]
Fate Therapeutics Announces Leadership Transition
29/11/2024
Bob Valamehr, Ph.D. MBA, To Become President and CEO January 1, 2025 Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 [...]
Apogee Therapeutics Announces Agenda for Virtual R&D Day
29/11/2024
SAN FRANCISCO and WALTHAM, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
29/11/2024
COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]
Narayana Health Issues Statement Regarding Spire Healthcare Group plc Under Rule 2.8 of the Takeover Code
29/11/2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
CORRECTION: RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
29/11/2024
SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer detection. The clearance enables RadNet’s DeepHealth and GE HealthCare collaboration to bring [...]
Eurobio Scientific : succès de l’OPA à l’issue de sa première période, réouverture de l’offre du 4 au 17 décembre
29/11/2024
Eurobio Scientific : succès de l’OPA à l’issue de sa première période, réouverture de l’offre du 4 au 17 décembre Paris, le 29 novembre 2024 – 15H30 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME) et EB [...]
Major shareholder announcement
29/11/2024
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and [...]
Mainz Biomed Announces Stock Split
29/11/2024
BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. ( NASDAQ:MYNZ ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]
Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
29/11/2024
Prototype development and feasibility testing underway for optimized subcutaneous delivery SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental [...]
TG Therapeutics to Participate in the Evercore HealthCONx Conference
29/11/2024
Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ET NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and [...]
Entourage Health Reports Strong Third Quarter 2024 Financial Results
29/11/2024
The Company achieved a total revenue of $13.6 million. Gross Profit Margins continue to demonstrate a solid performance with 30% growth year-over-year. SG&A achieves a significant reduction, reflecting the Company's [...]
Avricore Health Corporate Update: Effective Plan, Resources Result in Success
29/11/2024
VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “ Company ” or “ Avricore ”) reports on its third quarter results for 2024 where the Company continues to see rising [...]

Pages